Should I buy Goosehead Insurance, Inc. (GSHD) stock or is it too late?
⭐ The most reliable of them, either direction: Keefe, Bruyette & Woods — 67% of its targets hit on this sector (291 calls tested). It aims for $72 (+2.2 %), call made on July 24, 2026, maturing on July 24, 2027 (35 d ago).
Firm-by-firm track record on Goosehead Insurance, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 50 % | +19.0 % | 14 | $58 -18% |
| B of A Securities | 50 % | +7.3 % | 6 | $37 -47% |
| JMP Securities | 46 % | +1.4 % | 13 | $140 +99% |
| Piper Sandler | 39 % | -7.6 % | 18 | $72 +2% |
| Keefe, Bruyette & Woods | 25 % | -8.6 % | 8 | $72 +2% |
| UBS | 20 % | -18.8 % | 5 | $72 +2% |
✅ Reasons to believe
- 63% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
⚠️ Reasons to hesitate
- Even the most reliable firm on GSHD, BMO Capital (100% hit rate, 3 scored calls), only targets $55 (call made on February 18, 2026, maturing on February 18, 2027) (-22%) in its most recent call, and $79 (call made on November 25, 2025, maturing on November 25, 2026) (+12%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 8 ratings, 2 are neutral and 1 is a sell.
- Limited upside: the median target is only +2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on GSHD
Median target $72 (+2%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Goosehead Insurance, Inc. now?
We won't decide for you. The facts: 63% of analysts rate it a buy, median target $72 (+2%), and BMO Capital (most reliable on GSHD, 100%) targets $55. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Goosehead Insurance, Inc.?
The stated upside is small: the median target ($72) sits just +2% from the price ($70) (most reliable on GSHD: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Goosehead Insurance, Inc. still worth investing in?
It depends on the gap between the price ($70) and its estimated value: analysts target $72 on median (+2%), with 63% buys (most reliable on GSHD: BMO Capital, 100%). Cross-check with their real reliability on GSHD and the cautions above. Information, not advice.
What's the main risk in buying GSHD?
Even the most reliable firm on GSHD, BMO Capital (100% hit rate, 3 scored calls), only targets $55 (call made on February 18, 2026, maturing on February 18, 2027) (-22%) in its most recent call, and $79 (call made on November 25, 2025, maturing on November 25, 2026) (+12%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Goosehead Insurance, Inc. profile (consensus, analyst reliability, price target, performance).